Pentachloronitrobenzene disturbed murine ventricular wall development by inhibiting cardiomyocyte proliferation via

Xiaobo Gao1, Qinghua Dan1, Chen Zhang1

  • 1Department of Genetics, National Research Institute for Family Planning, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

PubMed

Insights

Maternal exposure to pentachloronitrobenzene (PCNB) disrupts heart development by inhibiting cardiomyocyte proliferation via the Atf3-Hec1 pathway, causing cardiac abnormalities and embryonic lethality.

Area of Science:

  • Developmental toxicology
  • Cardiovascular biology
  • Molecular genetics

Background:

  • Organochlorine fungicides like pentachloronitrobenzene (PCNB) are known teratogens, but the precise molecular mechanisms underlying PCNB-induced cardiotoxicity are not fully understood.
  • Cardiac malformations are a significant concern in developmental toxicology, necessitating research into the cellular and molecular pathways affected by environmental exposures.

Purpose of the Study:

  • To elucidate the molecular mechanism by which pentachloronitrobenzene (PCNB) exposure leads to cardiac developmental abnormalities.
  • To investigate the role of the Hec1 gene and its regulatory axis in PCNB-induced cardiotoxicity and cardiomyocyte proliferation.

Main Methods:

  • Oral administration of PCNB to pregnant mice to induce developmental toxicity.
  • Analysis of gene expression, focusing on Hec1 and Atf3, in developing cardiac tissues.
  • Assessment of cardiomyocyte proliferation, mitotic spindle formation, and chromosome segregation.
  • Cardiac-specific gene ablation studies to determine the in vivo function of Hec1.

Main Results:

  • PCNB exposure in mice resulted in hypoplastic cardiac walls with thinned compact myocardium.
  • PCNB significantly downregulated Hec1 expression, leading to aberrant mitotic spindles, chromosome missegregation, and arrested cardiomyocyte proliferation.
  • Cardiac-specific Hec1 ablation mimicked PCNB effects, causing thin myocardial walls and embryonic lethality.
  • Activating transcription factor 3 (ATF3) was identified as a transactivator of Hec1, and ATF3 or HEC1 overexpression rescued PCNB-induced defects.

Conclusions:

  • Maternal PCNB exposure disrupts embryonic cardiac development by inhibiting cardiomyocyte proliferation and impairing ventricular wall formation.
  • The downregulation of the Atf3-Hec1 signaling axis is a key mechanism contributing to PCNB-induced cardiotoxicity.
  • Targeting the Atf3-Hec1 pathway may offer therapeutic strategies to mitigate PCNB-related developmental cardiac defects.